The FDA is considering an overhaul of the agency's Medication Guide program and is seeking help from pharmacists and other providers to make the patient prescriptiondrug information program more effective.
The number of Medication Guide handouts that the FDA requires pharmacists to distribute with certain prescription medicines has increased significantly in recent years. Currently, pharmacists are required to distribute Medication Guides with some 240 prescription products, and it has become more common for these handouts to be required for entire classes of drugs (such as nonsteroidal anti-inflammatory drugs).
"We want to hear from manufacturers, distributors, pharmacies, health professionals, and patients about what concrete steps can be taken to ensure that consumers get the information they need to make informed decisions about the use of medicines," said Paul Seligman,MD, associate director for safety policy and communication at the FDA's Center for Drug Evaluation and Research.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs